Tyra Biosciences, Inc.
NASDAQ:TYRA
16.42 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -69.134 | -55.325 | -26.294 | -9.336 | -4.065 |
| Depreciation & Amortization
| 0.353 | 0.296 | 0.14 | 0.047 | 0.008 |
| Deferred Income Tax
| -9.369 | 0 | 0 | 0.002 | 0 |
| Stock Based Compensation
| 13.525 | 10.588 | 2.887 | 0.439 | 0 |
| Change In Working Capital
| 6.36 | -5.847 | -0.481 | 1.07 | 0.505 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 9.369 | 2.357 | 1.492 | 1.019 | 0.461 |
| Other Working Capital
| -3.009 | -8.204 | -1.973 | 0.051 | 0.044 |
| Other Non Cash Items
| 8.126 | 0.003 | 0.003 | 0.015 | 0.934 |
| Operating Cash Flow
| -50.139 | -50.285 | -23.745 | -7.763 | -2.618 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.77 | -0.559 | -0.661 | -0.312 | -0.02 |
| Acquisitions Net
| 0 | 0 | 0.016 | 0 | 0 |
| Purchases Of Investments
| -143.835 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.144 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -144.605 | -0.559 | -0.645 | -0.312 | -0.02 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -0.009 | -0.017 | -0.008 |
| Common Stock Issued
| 1.537 | 0.632 | 181.22 | 23.451 | 0.165 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.002 | 0.001 | 130.137 | 0.023 | 0.165 |
| Financing Cash Flow
| 1.537 | 0.001 | 311.348 | 23.434 | 0.157 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -193.207 | -50.212 | 286.958 | 15.359 | -2.481 |
| Cash At End Of Period
| 58.006 | 252.213 | 302.425 | 15.467 | 0.108 |